Skip to main content

Table 2 Mendelian randomization and colocalization analyses of circulating PCSK9 on HF in patients with CHD: Insights from the deCODE. dataset. HF: heart failure; CHD: Coronary heart disease; CI, Confidence interval; OR, Odds ratio

From: Proteome-wide mendelian randomization investigates potential associations in heart failure and its etiology: emphasis on PCSK9

Outcome

Methods

OR (95% CI)

P value

Colocalization Analysis PH4 (%)

HF in patients with CHD

IVW (P for heterogeneity = 0.560)

1.320 (1.226–1.421)

1.56E-13

99.993

 

Weighted median

1.317 (1.213–1.429)

4.72E-11

 
 

MR-Egger

1.273 (1.141–1.420)

0.023

 
 

MR-Egger regression

 

0.445

 
 

MR-PRESSO (no outliers detected)

0.613

Â